コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 d independently reviewed for hepatic surface nodularity.
2 eedle biopsy if required to evaluate thyroid nodularity.
3 ith 13 (34%) of these patients having antral nodularity.
4 th International Labour Office (ILO) grade 3 nodularity, 112 patients with less severe silicosis (ILO
5 ging included multiloculation (56.9%), mural nodularity (16.5%), and biliary ductal dilatation (17.7%
6 ial (RPE) atrophy (43%), RPE loss (14%), RPE nodularity (8%), photoreceptor loss (43%), inner segment
8 spectively scored qualitative (reticulation, nodularity, and total scores) and quantitative (contrast
9 patients (43%) demonstrated hepatic surface nodularity at pretransplant imaging, none of whom had ci
10 ividuals with medulloblastoma with extensive nodularity, four of 20 with desmoplastic/nodular medullo
11 liver surface, patients with hepatic surface nodularity had a significantly greater proportion with t
13 quantitative method to measure liver surface nodularity (LSN) from routine computed tomographic (CT)
14 o determine whether use of the liver surface nodularity (LSN) score, a quantitative biomarker derived
16 ral valve) manifested predominantly (74%) as nodularities of the aortic cusps and basal thickening of
17 ents with lung cancer, smooth enlargement or nodularity of the adrenal glands at baseline CT is not a
18 5.36; 95% confidence interval, 1.84-15.56), nodularity on endoscopy (relative risk, 3.98; 95% confid
19 uct IPMN and for branch-duct IPMN with mural nodularity or positive cytology irrespective of location
20 scopic abnormalities, that is, ulceration or nodularity (P = 0.0002; relative risk [RR] = 7.6; 95% co
21 e, location, septation, calcification, mural nodularity, pancreatic duct involvement, and presence of
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。